MARKET

ORXOF

ORXOF

Orexo Ab
OTCQX
0.082
NaN%
Closed 09:30 11/20 EST
OPEN
--
PREV CLOSE
0.082
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
7.08
52 WEEK LOW
0.082
MARKET CAP
28.46M
P/E (TTM)
0.060
1D
5D
1M
3M
1Y
5Y
1D
Orexo Presents OX640 Data on Epinephrine Levels and Stability
TipRanks · 11/13 09:16
Orexo, SVF Vaccines to Explore Powder-Based LNP-mRNA Vaccine Formulation
TipRanks · 11/11 08:00
Orexo Announces Two OX640 Data Presentations at ACAAI 2026
TipRanks · 11/10 08:40
Orexo Shareholders Approve Rights Issue and Financing Measures
TipRanks · 11/06 09:32
Orexo Sets Terms for SEK 253 Million Rights Issue
TipRanks · 11/02 21:49
Orexo Wins FDA Review of High‑Dose Naloxone Nasal Powder IZIPRY
TipRanks · 10/29 10:38
Orexo AB Earnings Call: Pipeline Progress Amid Strain
TipRanks · 10/26 00:10
Orexo Deepens R&D-Driven Transformation Amid Losses and Capital Raise
TipRanks · 10/22 05:35
More
About ORXOF
Orexo AB is a Sweden-based company active within the pharmaceutical industry. It focuses primarily on the development of new, patented drugs by combining documented substances with technologies, and the new treatments for respiratory and inflammatory diseases. The Company has four commercialized products, several projects developed in partnership, as well as three development programs. The Company's registered products are: Abstral for the treatment of break through cancer pain, sold by ProStrakan Group plc in Europe, the United States and Canada; the sleeping pill Edluar, sold by Meda in the United States and Canada; as well as two products for the diagnosis of Helicobacter pylori which are being marketed by the subsidiary, Kibion AB. The Company operates through subsidiaries: Pharmacall AB, Noster System AB, Orexo UK, and Pharmakodex Ltd, among others. In December 2013, Kyowa Hakko Kirin Co., Ltd (KHK), with the licensed right to Abstral, commenced the launch of it in Japan.

Webull offers Orexo AB stock information, including OTCQX: ORXOF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ORXOF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ORXOF stock methods without spending real money on the virtual paper trading platform.